1. Retinyl methyl ether was converted into vitamin A in vitamin A-deficient rats regardless of whether administered by oral, intraperitoneal, intramuscular or subcutaneous route; intramuscular administration seemed to be the best for conversion as well as storage. 2. Significantly, unchanged retinyl methyl ether was also found in the liver after oral administration but not after administration by other routes. 3. Oral administration of 1mg of retinyl methyl ether led to a progressive increase in liver vitamin A with time reaching a value of 16% of administered dose after 24h. No retinyl methyl ether was detectable in liver at any time-interval in this experiment. 4. Conversely, oral administration of 4mg of retinyl methyl ether/day for 4 days led to the accumulation of 25% of the dose as unchanged!retinyl methyl ether in the liver 1 day after the last dose; however, it was gradually but completely converted into vitamin A over a period of 18 days. 5. The significance of these findings with special reference to the fundamental metabolism of vitamin A, the site of conversion of retinyl methyl ether into vitamin A, the relative efficiency of various routes of administration and its biological activity are discussed.
Retinyl methyl ether, a synthetic derivative of retinol, is nearly as effective as retinol in promoting growth (Hanze, Conger, Wise & Weisblat, 1946; Isler et al. 1949) . Its biological activity might be effected by the compound itself, as in the case of retinoic acid (Oroshnik, Karmas & Mebane, 1952) , or might be due to retinol formed by cleavage of the ether as originally suggested by Isler (1950) . The fact that retinyl methyl ether is effectively converted into retinol by the rat in vivo (Thompson & Pitt, 1963) supports the latter view. However, detailed studies on the metabolism and storage of this analogue of vitamin A have not previously been conducted.
In the present work the metabolism of retinyl methyl ether in the rat in vivo has been examined in some detail: (1) by measuring the storage of vitamin A derivatives in the liver and intestine after administration of the compound by various routes; (2) by determining the amount of retinol, retinyl palmitate and unchanged retinyl methyl ether in these organs as a function ofthe route of administration, time and dose.
MATERIALS AND METHODS
Chemicals. all-tran8-Retinol was obtained from Distil- lation Products Industries, Rochester, N.Y., U.S.A., and retinyl palmitate from K & K Laboratories Inc., Plain- view, N.Y., U.S.A. Retinyl methyl ether was a gift from Professor 0. Isler, Hoffmann-La Roche and Co. Ltd., Basle, Switzerland; it was also synthesized as described by Hanze et al. (1946) . All other reagents and chemicals were of analytical grade.
Preparation of retinyl methyl ether for metabolic studies. Retinyl methyl ether was prepared just before use at a concentration of mg/0.1 ml of refined vegetable oil containing 0.5 mg of oc-tocopherol for oral, intraperitoneal and subcutaneous administrations; it was dispersed in a solution containing 6.25% Tween 40 and 1.0% bovine serum albumin at a concentration of 1 mg/0. 1 ml for intramuscular administration.
Animals. Vitamin A-deficient rats (Wistar strain) were used while in the 'weight-plateau' stage, as described by For quantitative separation and isolation of vitamin A derivatives, t.l.c. was carried out on alumina G plates by using the same solvent system since the recoveries were more than 95%, unlike those from silica gel G plates. However, alumina G plates were employed only with saponified extracts because retinyl palmitate and retinyl methyl ether failed to separate distinctly from each other on them.
Determination&. The concentrations of retinol, retinyl palmitate and retinyl methyl ether in light petroleum (b.p.40-60'C) were determined in a Cary 15 recording spectrophotometer, by using ElCm values of 1830, 1595 (Cama, Collins & Morton, 1951) and 1626 (present investigation) respectively at 325nm in light petroleum (b.p. 40-60°C). For impure extracts, the correction formula of Cama et al. (1951) was used.
RESULTS

Oral administration. Three vitamin A-deficient
rats were given retinyl methyl ether orally (500,ug! day per rat) for 10 days. Symptoms of vitamin A deficiency were alleviated in all treated animals within 2 days after receipt of the first dose. The average weight gain of the rats during this period was 41g. At 24h after the last dose the rats were killed and their livers and intestines were pooled and analysed for vitamin A derivatives.
As shown in Table 1 , 11% of the administered dose was found in the liver as unchanged retinyl methyl ether and 24% was present as retinyl palmitate plus retinol. The intestine contained both vitamin A and retinyl methyl ether.
Parenteral administration. Three vitamin Adeficient rats were given retinyl methyl ether intraperitoneally (500,g/day per rat) for 10 days. The rats were relieved of all symptoms of vitamin A deficiency within 2 days and gained an average of about 35g in weight during the period. The rats were killed 24h after the last dose and the livers and intestines were pooled and analysed.
As indicated in Table 1 , retinyl methyl ether was not detected in the liver after intraperitoneal administration. On the other hand, the recovery of retinyl palmitate plus retinol was 37% of the administered dose, much higher than when the retinyl methyl ether was administered orally. However, both retinyl methyl ether and retinol were detected in intestinal extracts. Intramuscular administration. Three vitamin Adeficient rats were given retinyl methyl ether intramuscularly (500,g/day per rat) for 10 days. The rats were alleviated of vitamin A-deficiency symptoms within 1 day and gained on an average about 38g in body weight during this period. They were killed 24h after the last dose and the livers, intestines and the muscular tissue around the site of injection were pooled and analysed.
It is apparent from (Table 2) . To study the metabolic fate of retinyl methyl ether after it reaches the liver, larger doses (4mg/ day per rat) were administered to vitamin Adeficient rats for 4 days. The animals were killed at various time-intervals after the last dose and the livers were analysed. As shown in Table 3 Vol. 122taken up by the intestinal mucosa during absorption (Ganguly, 1967) . There have been instances, however, indicating that the fed ester is absorbed as such across the intestine, as reported for retinyl acetate (Shellenberger, Parrish & Sanford, 1964) and retro-retinyl acetate (Murray & Erdody, 1966) . On the other hand, John, Lakshmanan & Cama (1967) could detect only retro-retinyl palmitate but not the acetate ester in the livers even after massive oral doses of retro-retinyl acetate to vitamin Adeficient rats, showing thereby that it has to be hydrolysed to the free alcohol. Retinyl methyl ether is also hydrolysed to the free alcohol before being absorbed across the intestine (Table 2 ) except when massive doses were fed (Tables 1 and 3) . Hence under physiological conditions it seems reasonable that no form of vitamin A ester can be absorbed as such across the intestine except under special circumstances. Even then it is only the unnatural synthetic derivatives of vitamin A that have been reported to escape hydrolysis to the free alcohol.
The finding that the extent of conversion of retinyl methyl ether into vitamin A and subsequent storage in the liver (Table 1) varies from 45% when it is given intramuscularly to 37 % when it is given intraperitoneally to 24% when it is given orally implies that the intramuscular route of administration could well be the most efficient for absorption, transport and storage ofvitamin A compounds. The recovery in the liver of only 1% of a subcutaneously administered single dose after 19 days indicates that the bulk of the retinyl methyl ether is removed faster than could be accounted for by the metabolic needs of the animal. Nonetheless it is of note that a single 1 mg subcutaneous dose of retinyl methyl ether can sustain the normal growth of a vitamin A-deficient rat over a period of 19 days.
The detection of retinyl methyl ether in the liver after its oral administration but not after parenteral, intramuscular or subcutaneous administration (Table 1) suggests that the liver is the major, if not the only, site for conversion of retinyl methyl ether into retinol. However, a cell-free system from rat liver has now been isolated that can catalyse the conversion of [3H]retinyl methyl ether into [3H]-retinol (Narindrasorasak, Lakshmanan & Olson, 1970, and unpublished work) . It is probably a microsomal mono-oxygenase requiring molecular oxygen, NADPH and reduced pteridine as cofactors. Further, no form of vitamin A was detectable in the intestine after administration ofretinyl methyl ether by various routes other than by oral route. All these can be explained on the basis that retinyl methyl ether is transported directly to the liver, where it is efficiently converted into vitamin A. Even when administered orally it is slowly but completely converted into vitamin A within a period of 18 days (Table 3 ). Failure to detect any vitamin A in the muscular tissue around the site of aclministration seems to rule out this tissue as another site for conversion of retinyl methyl ether into vitamin A.
The appearance of retinol in the intestine 6h after the oral administration of retinyl methyl ether (Table 2 ) strongly favours the intestine as another site of the latter's conversion into vitamin A. It also implies that retinyl methyl ether might first be cleaved to retinol before being esterified to retinyl palmitate and stored in the liver. However, the presence of retinyl methyl ether in the intestine even after 24h (Table 2) indicates that its conversion into vitamin A is a slow process in the intestine. Apparently rat intestine is efficient enough to prevent any unchanged retinyl methyl ether from reaching the liver when the rat is given a single oral 1mg dose of retinyl methyl ether (Table 2 ), but not when it is loaded with excessive doses (Tables 1  and 3 ).
The fact that retinyl methyl ether can be detected in the liver unchanged in appreciable amounts (Table 3) after massive oral administration implies that, although the intestine may be an important site for conversion of dietary retinyl methyl ether, it seems to have a threshold beyond which excess of retinyl methyl ether escapes cleavage and thus is absorbed as such. This accounts for 27% of the total storage of vitamin A derivatives in the liver as retinyl methyl ether at 24h (Table 3) . It must be pointed out that Thompson & Pitt (1963) never detected any unchanged retinyl methyl ether in the liver after the oral administration of 800,ug/day per rat over a period of 29 days. However, since dosage, time-interval and strain of the rats used in their study were different from the present study, the two results are not strictly comparable. Thus the present investigations clearly show that the efficiency with which retinyl methyl ether is convetted into vitamin A in the rat irrespective of the route of its administration is commensurate with its high biological activity. 
